|February 2000 (Volume 7, Issue 2)
Article 157: Surfing for Study Subjects
Article 158: EMR: Gearing Up for Prime Time
- Current use of electronic medical records is very low, but pending HIPAA requirements will likely accelerate adoption rates.
- EMRs are expected to play a dramatic role in reducing development cycle times and costs; the question is, when will they begin to do so?
Article 159: CentreStage Europe: Russian Market Meets its First SMO
- Despite some ongoing problems, the Russian market is becoming a more attractive location in which to conduct clinical trials due to high levels of investigator motivation and a treatment-naive patient population. Geny, a Boston-based SMO, was founded specifically to navigate the problems still to be encountered in Russia when conducting trials.
Article 160: Eye On: Prostate Cancer
- CenterWatch editorial has identified 52 therapies in the clinical research pipeline for the treatment of the most common cancer diagnosed in men--prostate cancer. Primary areas of research include gene therapy, immunologic agents, vaccines, anti-angiogenesis and drug delivery.